These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 317183)

  • 1. Effect of preoperative high-dose methotrexate and leucovorin rescue on incidence of wound infection in rats.
    Kraft RL; Goldberg NH; Ariyan S
    Surg Forum; 1979; 30():537-9. PubMed ID: 317183
    [No Abstract]   [Full Text] [Related]  

  • 2. An experimental model to determine the effects of adjuvant therapy on the incidence of postoperative wound infection: II. Evaluating preoperative chemotherapy.
    Ariyan S; Kraft RL; Goldberg NH
    Plast Reconstr Surg; 1980 Mar; 65(3):338-45. PubMed ID: 6766559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biochemical and pharmacokinetic effects of leucovorin after high-dose methotrexate in a murine leukemia model.
    Sirotnak FM; Donsbach RC; Moccio DM; Dorick DM
    Cancer Res; 1976 Dec; 36(12):4679-86. PubMed ID: 1087182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-dose methotrexate with leucovorin rescue.
    Akahoshi M
    Cancer Nurs; 1978 Aug; 1(4):319-25. PubMed ID: 307982
    [No Abstract]   [Full Text] [Related]  

  • 5. Leucovorin and maximum tolerated dose toxicity of methotrexate in rats.
    Fuskevåg OM; Kristiansen C; Lindal S; Aarbakke J
    Pediatr Hematol Oncol; 2000 Dec; 17(8):651-8. PubMed ID: 11127396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preliminary report on the effects of a four drug cytoxic protocol on wound healing in the rat.
    Hughes KB
    Clin Oncol; 1981 Sep; 7(3):235-40. PubMed ID: 6177465
    [No Abstract]   [Full Text] [Related]  

  • 7. [The method of leucovorin administration in high dose methotrexate regimen (author's transl)].
    Taguchi H
    Rinsho Ketsueki; 1981 Nov; 22(11):1687-99. PubMed ID: 7040726
    [No Abstract]   [Full Text] [Related]  

  • 8. Letter: Methotrexate with citrovorum-factor rescue.
    Falk L
    N Engl J Med; 1975 Jun; 292(26):1406-7. PubMed ID: 1079571
    [No Abstract]   [Full Text] [Related]  

  • 9. Prognostic factors in the response of primary osteogenic sarcoma to preoperative chemotherapy (high-dose methotrexate with citrovorum factor).
    Juergens H; Kosloff C; Nirenberg A; Mehta BM; Huvos AG; Rosen G
    Natl Cancer Inst Monogr; 1981 Apr; (56):221-6. PubMed ID: 6975439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [High dose of methotrexate-leucovorin treatment in advanced non-Hodgkin's lymphoma].
    Kawarabayashi K; Yoshikawa T; Sannomiya Y; Hashimoto K; Araki J; Park K; Tatumi Y; Kamitani T; Im T; Tatumi N
    Gan To Kagaku Ryoho; 1983 Dec; 10(12):2493-9. PubMed ID: 6606395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of rescue treatment with high doses of methotrexate (MTX) followed by leucovorin (LV) on neoplastic cells (HeLa line) and normal sensitized peripheral lymphocytes].
    Ruano A; Alvarez-Rodríguez Y; Valladares Y
    Rev Esp Oncol; 1982; 29(4):665-73. PubMed ID: 6985426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Markedly improved efficacy of edatrexate compared to methotrexate in a high-dose regimen with leucovorin rescue against metastatic murine solid tumors.
    Sirotnak FM; Otter GM; Schmid FA
    Cancer Res; 1993 Feb; 53(3):587-91. PubMed ID: 8425192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Memorial Sloan Kettering Cancer Center experience with outpatient administration of high dose methotrexate with leucovorin rescue.
    Zelcer S; Kellick M; Wexler LH; Gorlick R; Meyers PA
    Pediatr Blood Cancer; 2008 Jun; 50(6):1176-80. PubMed ID: 18266225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of malignant neoplasms in advanced stages with HDMTX-CF Rescue (high-dose methotrexate-citrovorum factor rescue)].
    Paparopoli G; Agostara B; Di Girolamo G
    Clin Ter; 1981 May; 97(3):271-81. PubMed ID: 6974631
    [No Abstract]   [Full Text] [Related]  

  • 15. Damaging effects of chronic low-dose methotrexate usage on primary bone formation in young rats and potential protective effects of folinic acid supplementary treatment.
    Fan C; Cool JC; Scherer MA; Foster BK; Shandala T; Tapp H; Xian CJ
    Bone; 2009 Jan; 44(1):61-70. PubMed ID: 18976724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [High-dose methotrexate with citrovorum factor rescue in osteogenic carcinoma].
    Levi M; Sulkes A; Katz E; Rizel S; Biran S
    Harefuah; 1980 Sep; 99(5-6):110-3. PubMed ID: 6970707
    [No Abstract]   [Full Text] [Related]  

  • 17. The effect of high dosage of methotrexate, associated with folinic acid, on the suppression of tuberculin sensitivity in guinea-pigs.
    Hart PD; Rees RJ; Niven JS
    Clin Exp Immunol; 1968 Jan; 3(1):91-8. PubMed ID: 5300374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-dose methotrexate with folinic acid rescue.
    Bender JF; Grove WR; Fortner CL
    Am J Hosp Pharm; 1977 Sep; 34(9):961-5. PubMed ID: 333910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of high-dose methotrexate and leucovorin on murine hemopoietic stem cells.
    Pannacciulli I; Massa G; Bogliolo G; Ghio R; Sobrero A
    Cancer Res; 1982 Feb; 42(2):530-4. PubMed ID: 6976827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-dose methotrexate with leucovorin rescue plus vincristine in advanced sarcoma: a Southwest Oncology Group study.
    Vaughn CB; McKelvey E; Balcerzak SP; Loh K; Stephens R; Baker L
    Cancer Treat Rep; 1984 Feb; 68(2):409-10. PubMed ID: 6607770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.